Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Upbound Group
UPBD
$1.16B
| $4.42M | ﹤0.01% |
153,188
-2,871
| -2% | -$75K |
|
2127
PUT
Mondelez International
MDLZ
$79.9B
| $4.42M | ﹤0.01% |
80,200
+46,400
| +137% | +$2.48M |
|
|
BDN
2128
Brandywine Realty Trust
BDN
$554M
| $4.41M | ﹤0.01% |
280,201
-94,377
| -25% | -$1.43M |
|
|
BEAT
2129
DELISTED
BioTelemetry, Inc.
BEAT
| $4.41M | ﹤0.01% |
95,199
+56,929
| +149% | +$2.47M |
|
|
EFOR
2130
Everforth Inc
EFOR
$1.32B
| $4.41M | ﹤0.01% |
62,109
+26,820
| +76% | +$1.75M |
|
2131
Alkermes
ALKS
$8.25B
| $4.39M | ﹤0.01% |
215,175
-47,163
| -18% | -$937K |
|
2132
Manhattan Associates
MANH
$11.4B
| $4.39M | ﹤0.01% |
55,006
-28,615
| -34% | -$2.28M |
|
2133
Jack in the Box
JACK
$335M
| $4.38M | ﹤0.01% |
56,119
+19,300
| +52% | +$1.6M |
|
2134
PUT
Vodafone
VOD
$37.4B
| $4.38M | ﹤0.01% |
226,500
-24,500
| -10% | -$488K |
|
|
CALY
2135
Callaway Golf Company
CALY
$3.14B
| $4.38M | ﹤0.01% |
206,422
+3,425
| +2% | +$70.1K |
|
2136
ASML
ASML
$669B
| $4.38M | ﹤0.01% |
14,787
+1,387
| +10% | +$375K |
|
2137
Insight Enterprises
NSIT
$4.38B
| $4.36M | ﹤0.01% |
62,025
+17,909
| +41% | +$1.13M |
|
|
FTV.PRA
2138
DELISTED
Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A
FTV.PRA
| $4.36M | ﹤0.01% |
4,477
-15,034
| -77% | -$14M |
|
2139
CALL
Becton Dickinson
BDX
$48.2B
| $4.35M | ﹤0.01% |
16,400
-820
| -5% | -$204K |
|
2140
CALL
Avis
CAR
$5.02B
| $4.35M | ﹤0.01% |
135,000
+16,900
| +14% | +$507K |
|
2141
CALL
Ionis Pharmaceuticals
IONS
$9.4B
| $4.35M | ﹤0.01% |
72,000
+14,700
| +26% | +$876K |
|
|
JJP
2142
DELISTED
iPath Series B Bloomberg Precious Metals Subindex Total ReturnSM ETN
JJP
| $4.35M | ﹤0.01% |
80,000
| – | – |
|
2143
Ingredion
INGR
$6.58B
| $4.35M | ﹤0.01% |
46,760
-103,893
| -69% | -$8.73M |
|
2144
Ares Management
ARES
$30.9B
| $4.34M | ﹤0.01% |
121,647
-25,654
| -17% | -$797K |
|
2145
ESCO Technologies
ESE
$7.92B
| $4.33M | ﹤0.01% |
46,861
+17,188
| +58% | +$1.47M |
|
2146
Energizer
ENR
$1.55B
| $4.33M | ﹤0.01% |
86,302
+37,306
| +76% | +$1.72M |
|
2147
FormFactor
FORM
$9.17B
| $4.33M | ﹤0.01% |
166,660
+16,289
| +11% | +$367K |
|
2148
Integer Holdings
ITGR
$4.26B
| $4.32M | ﹤0.01% |
53,776
+12,380
| +30% | +$945K |
|
|
ARI
2149
Apollo Commercial Real Estate
ARI
$885M
| $4.32M | ﹤0.01% |
236,264
+63,335
| +37% | +$1.17M |
|
2150
PUT
Accenture
ACN
$108B
| $4.32M | ﹤0.01% |
20,500
-108,400
| -84% | -$21.1M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.